South Africans fly with Eagle
South African cosmetics company Amka will become a cornerstone investor in ASX-bound Chinese nutrition products firm Eagle Health.
UQ breast cancer drug maker raises $21.5m
The Medical Research Commercialisation Fund has poured $21.5 million into UQ linked drug developer QUE Oncology.
Pharma giant funds Monash rheumatoid arthritis research
Janssen Biotech, part of global giant Johnson & Johnson, has agreed to fund research by a team of scientists led by one of Monash University's star researchers into rheumatoid arthritis.
Ex Primary Health boss denies working with Chinese
Former boss of Primary Health Care Peter Gregg has strongly denied he is working with major shareholder and possible suitor Chinese firm Jangho Group.
Demetriou sticks to his corporate goals
Andrew Demetriou insists he does not want to go back to sport.
Blue Sky investing in Adelaide medical centres
Blue Sky Private Equity expects to invest a further $10 million during the investment period to acquire a further 15 to 20 clinics.
Rex leaves McNally pushing Ramsay uphill
How long can incremental pain be absorbed and double-digit earnings growth maintained?
Will I lose my vision, as my father did?
If you had a parent with macular degeneration, you have a 50 per cent chance of getting it too. Here's what one man is doing about it.
Technology is starting to disrupt multiple sclerosis
New digital technology is changing how we treat MS and how we raise funds to fight it.
Peanut allergy treatment backed with $10m
A treatment for peanut allergy which promises to allow children to eat peanuts as part of their regular diet has been backed by the governme...
